Illumina, Inc. (NASDAQ: ILMN) announced that GeneDx, a leader in genetic testing for rare diseases, is piloting Illumina's ...

As more people start to opt for genetic carrier testing ahead of conception, doctors and parents-to-be are facing difficult ...

Gene therapy is linked to better nonmotor outcomes in spinal muscular atrophy type 1 compared to first-line nusinersen, new ...

For people with spinal muscular atrophy, physical therapy can help support mobility, strength, and quality of life, regardless of SMA type.

In what is being termed a major victory, Natco Pharma has won a legal battle against Swiss pharma giant Roche, allowing the ...

AnnJi Pharmaceutical Co., Ltd. (AnnJi, TWSE: 7754) announced that the Phase 2a clinical result of AJ201 for spinal and bulbar ...

Natco Pharma has secured yet another favourable ruling against a drug innovator, allowing it to sell a generic version of a ...

Muscle atrophy is when muscles shrink from lack of use. It can occur due to an injury, a neurological condition, or from a ...

SMA Europe has launched an online tool designed to help patients, doctors, and others in the spinal muscular atrophy (SMA) ...

Natco Pharmaceuticals wins case against international pharmaceutical giant Roche; patients of spinal muscular atrophy heave a ...

Valued at a market cap of $22.1 billion, Biogen Inc. (BIIB) is a top biotechnology company. Headquartered in Cambridge, ...

The Delhi High Court dismissed Roche’s appeal, clearing the final legal hurdle for its generic Risdiplam launch ...